SCHEMBL6089244

SCHEMBL6089244

CCC(CC)(c1ccc(F)cc1)c1c[nH]c2c(N)cccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 6/20 0.39
PGR P06401 6/20 0.39
NR3C2 P08235 6/20 0.39
AR P10275 6/20 0.39
IMPDH2 P12268 1/20 0.36
PARP1 P09874 2/20 0.32
MPO P05164 3/20 0.32
SLC6A4 P31645 3/20 0.32
CLK1 P49759 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
GPR84 Q9NQS5 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
NSD2 O96028 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6089364 0.83 NR3C1 (0.39) NR3C1PGRNR3C2ARMPO
SCHEMBL6091991 0.82 AR (0.38) NR3C1PGRNR3C2ARGPR84
SCHEMBL6091511 0.81 NR3C1 (0.40) NR3C1PGRNR3C2ARIMPDH2
SCHEMBL6091351 0.80 NR3C1 (0.48) NR3C1PGRNR3C2ARNSD2
SCHEMBL6090466 0.79 DNA2 (0.42) NR3C1PGRNR3C2ARPARP1
SCHEMBL6245404 0.78 TAAR1 (0.33) IMPDH2SLC6A4TSHRMEN1LMNA
SCHEMBL6091133 0.78 NR4A2 (0.46) GPR84ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL8327159 0.77 NR3C1 (0.50) NR3C1PGRNR3C2ARPARP1
SCHEMBL6090427 0.77 NR3C1 (0.67) NR3C1PGRNR3C2AR
SCHEMBL6090483 0.77 NR3C1 (0.43) NR3C1PGRNR3C2ARMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R NR3C1 4/4885PGR 148/4885NR3C2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.